You are using an older version of Internet Explorer that is not supported on this site. Please upgrade for the best experience.

Lymphoma Trials

Click on a trial to find out the eligibility requirements and who to contact if you have questions about participating.

Page 1 of 1 | Results 1 - 4 of 4

A phase II trial of chemotherapeutic agents in patients with diffuse large B-Cell lymphoma

The purpose of this study is to find out what effects, good and/or bad, the addition of lenalidomide to standard chemotherapy (RCHOP)
Syed Ali, MD
Cancer - Lymphoma, Cancer

  • D’Amour Center for Cancer Care, 3350 Main Street, Springfield, MA
  • Baystate Franklin Medical Center, 164 High Street, Greenfield, MA

Active

Molecular Analysis for Therapy Choice (MATCH)

John McCann, MD
Cancer, Cancer - Brain, Cancer - Breast, Cancer - Colon, Cancer - Esophogus, Cancer-Gynecologic, Cancer - Kidney, Cancer - Leukemia, Cancer - Lung, Cancer - Lymphoma, Cancer - Melanoma, Cancer - Multiple Myeloma, Cancer - Pancreatic, Cancer - Prostate

D’Amour Center for Cancer Care, 3350 Main Street, Springfield, MA

Recruiting

Nivolumab and Ipilimumab in Treating Patients With Rare Tumors (DART)

John McCann, MD
Cancer, Cancer - Brain, Cancer - Breast, Cancer - Colon, Cancer - Esophogus, Cancer-Gynecologic, Cancer - Kidney, Cancer - Leukemia, Cancer - Lung, Cancer - Lymphoma, Cancer - Melanoma, Cancer - Multiple Myeloma, Cancer - Pancreatic, Cancer - Prostate

  • D’Amour Center for Cancer Care, 3350 Main Street, Springfield, MA
  • Baystate Franklin Medical Center, 164 High Street, Greenfield, MA   

Recruiting

Risk-Adapted Chemotherapy in Treating Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia or Localized B-Lineage Lymphoblastic Lymphoma

Joanna Luty, MD
Cancer, Cancer - Lymphoma, Cancer - Pediatric

D’Amour Center for Cancer Care, 3350 Main Street, Springfield, MA

Active
Page 1 of 1 | Results 1 - 4 of 4